The first commercial ELISA kits optimized for detecting infliximab biosimilar Remsima® levels and immunogenicity for the first biosimilar

Matriks Biotek® produced SHIKARI® Q-REMS and S-AIR as the  first ELISA kits for the biosimilar of Infliximab, CT-P13 (Remsima®)and now also offers to develop custom ELISA kits for your biosimilars or biologics on contract manufacturing basis depending on the molecule provided. Matriks Biotek® is the first company to commercialize SHIKARI® ELISA kits for biological drug testing to measure trough levels and anti drug antibodies (immunogenicity) since 2008. 

Pricing for SHIKARI® Q-REMS and S-AIR is 450 Euro plus shipment per kit for a limited time until the end of September 2016. 

Do not forget to add code "Q-REMS" in your purchase order in your e-mail to info@matriksbiotek.com  

Ask for all 23 SHIKARI®  ELISA kits for biological drug testing or for your custom needs ..